
We are excited to announce the merger of Syner-G BioPharma Group and Sequoia Biotech Consulting, joining forces to deliver integrated solutions for life sciences.
Read the Press Release | Learn more about Sequoia
Advancing scientific innovation and improving patient outcomes through trusted, expert guidance at every stage of drug development.



About Syner-g
Who We Are
What We Do
Pharmaceutical Development (CMC)
Pharmaceutical Development (CMC)
Regulatory Strategy & Submissions
Regulatory Strategy & Submissions
Functional Outsourcing Partnerships
Functional Outsourcing Partnerships
Medical Writing
Medical Writing
Quality & Compliance
Quality & Compliance
Our Capabilities
Why Syner-G?
Number of Years of Industry Experienced Sr. Consultants
Number of Employee and
Number of Ph.Ds World-wide
Number of INDs and IND Amendments Filed
Number of Post-Approval Major Supplements
Years As An Organization (aggregate across all Syner-G companies)
Assets Supported
Number of Agency Meetings



Careers
Latest Developments and Insights

The Real Cost of Uncertainty: Why On-Again, Off-Again Tariffs Hurt Biotech Supply Chains
In drug development, and especially for smaller and medium-sized biotech companies, consistency is everything. From regulatory pathways to R&D timelines to global supply chains — predictability enables progress. But there’s one growing source of disruption that biotech leaders are increasingly…
Read Full Article

Accelerating a Cytotoxic Peptide-Drug Conjugate to IND: A Medicinal Chemist’s Journey to IND with Syner-G BioPharma Group
As a medicinal chemist with experience in large pharmaceutical companies, I’ve spent my career designing and optimizing drug candidates. But when I was tasked with advancing a highly potent cytotoxic peptide-drug conjugate (PDC) toward IND submission, I found myself in…
Read Full Article

Navigating Analytical Method Comparability and Equivalency Under ICH Q14: A New Era for Analytical Procedure Lifecycle Management
The landscape of analytical development is continually evolving. With the introduction of ICH Q14: Analytical Procedure Development, the pharmaceutical and biotech sectors now have a formalized framework to guide the creation, validation, and lifecycle management of analytical methods. To keep…